mouse monoclonal anti fhl2 (Hycult Biotech)


Structured Review

Mouse Monoclonal Anti Fhl2, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti fhl2/product/Hycult Biotech
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury"
Article Title: Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
Journal: Cells
doi: 10.3390/cells9010248

Figure Legend Snippet: Primer sequences for quantitative real-time PCR.
Techniques Used:

Figure Legend Snippet: Fhl2 expression and effect of Fhl2 deficiency on hepatocellular injury and inflammation in the mouse model of bile duct ligation (BDL). Fhl2 -deficient ( Fhl2 -ko) and wild type (wt) mice were either bile duct ligated (BDL) or sham-operated (CTR). ( A ) Fhl2 mRNA levels in wt BDL and CTR mice analyzed by qRT-PCR. ( B ) Representative hematoxylin and eosin stainings of liver tissue samples (20× magnification). ( C ) ALT (alanine aminotransferase) and ( D ) bilirubin serum levels. ( E ) Hmox-1 and ( F ) Mcp-1 mRNA expression levels in liver tissue analyzed by qRT-PCR. ( G ) Immunohistochemical CD3 staining of liver tissue samples (20× magnification). ( H ) Il-1 and ( I ) Tnf mRNA expression levels in liver tissue analyzed by qRT-PCR. (*: p < 0.05).
Techniques Used: Expressing, Ligation, Quantitative RT-PCR, Immunohistochemical staining, Staining

Figure Legend Snippet: Effect of Fhl2 deficiency on hepatic fibrosis in the mouse model of bile duct ligation (BDL). Fhl2 -deficient ( Fhl2 -ko) and wild type (wt) mice were either subjected to BDL or were sham-operated (CTR). ( A ) Hepatic α-sma mRNA expression levels. ( B ) Immunohistochemical α-sma staining of liver tissue sections (20× magnification). Hepatic ( C ) Tgf-β and ( D ) Col1a1 mRNA expression levels. (E) Sirius Red/Fast Green staining of liver tissue sections (20× magnification). Hepatic ( F ) Mmp1 , ( G ) Mmp2 , ( H ) Mmp9 , and ( I ) Pai-1 mRNA expression levels in liver tissue analyzed by qRT-PCR. (*: p < 0.05).
Techniques Used: Ligation, Expressing, Immunohistochemical staining, Staining, Quantitative RT-PCR

Figure Legend Snippet: Effect of FHL2 depletion on bile acid-induced hepatocellular injury in vitro. ( A , B ) FHL2 mRNA and protein expression in HepG2 cells transfected with si-pools against FHL2 (siFHL2) and si-control-pools (siCtr). ( C ) Representative microscopical images 72 h after transfection (10X magnification). ( D ) Quantification of lactate dehydrogenase (LDH) release into the supernatant. ( E ) FHL2 , ( F ) p47phox , and ( H ) BAX mRNA, and ( G ) B-cell lymphoma 2 (BCL2) protein expression after treatment with deoxycholic acid (DCA) for 24 h and control cells (CTR). (*: p < 0.05).
Techniques Used: In Vitro, Expressing, Transfection

Figure Legend Snippet: Effect of FHL2 depletion on bile acid metabolism. HepG2 cells were transfected with si-pools against FHL2 (siFHL2) and si-control-pools (siCtr). Analysis of ( A ) CYP7A1 , ( B ) NTCP , ( C ) BSEP , and ( D ) MRP2 mRNA expression after treatment with deoxycholic acid (DCA) for 24 h and control cells (CTR). (*: p < 0.05).
Techniques Used: Transfection, Expressing

Figure Legend Snippet: Effect of FHL2 depletion on pro-fibrogenic gene expression in hepatic stellate cells in vitro. ( A ) FHL2 mRNA expression during activation of primary human hepatic stellate cells (HSCs). ( B , C ) FHL2 mRNA and protein expression in LX-2 cells transfected with si-pools against FHL2 (siFHL2) and si-control-pools (siCtr). ( D ) Representative microscopical images 72 h after transfection (10× magnification). ( E , F ) α-SMA mRNA and protein expression. ( G ) COL1A1 , ( H ) TGF-β , ( I ) MMP1 , ( J ) MMP3 , ( K ) MMP2 , ( L ) MMP9 and ( M ) MMP10 mRNA expression and ( N , O ) MMP13 and ( P , Q ) MMP14 mRNA and protein expression 72 h after transfection. (*: p < 0.05).
Techniques Used: Expressing, In Vitro, Activation Assay, Transfection